Alternative Investments… Climate-Aware Capital Markets and the Imperative of Private Capital Accountability 16 Mar 2026March 13, 2026 Introduction Climate change has moved decisively from the margins of environmental policy into the core architecture of global finance. What was once framed primarily as an environmental externality is now…
Alternative Investments… Unlocking Profit in Sports: Investment Strategies Revealed 11 Apr 2025April 13, 2025 Sports investing has seen significant growth in recent years as franchises, leagues, media rights, and brand-driven businesses (such as sports apparel and streaming) increase in value. What was once limited…
Alternative Investments… The Cardiac Implant Market 27 Sep 2024September 30, 2024 To effectively track the cardiac implant market, which includes devices such as pacemakers, defibrillators, heart valves, and left ventricular assist devices (LVADs), a comprehensive approach is required. This involves combining…
Equity… Patient Engagement in the Pharmaceutical Industry and Investor Perception 13 Oct 2023September 19, 2024 Patient engagement has become an increasingly important factor in the pharmaceutical industry, influencing various aspects of drug development, marketing, post-market surveillance, risk management, investor perception, cost savings, and regulatory and…
Asset Allocation… Healthcare Investments in Asia 9 Oct 2023September 19, 2024 The key macro drivers for healthcare investments in various countries in Asia include demographics, economic growth, healthcare infrastructure, government policies and regulations, technological advancements, disease prevalence, insurance penetration, cultural factors,…
Private Equity… Strategies That Chinese Small and Medium-Sized Enterprises Use to Attract Venture Capital 24 Jun 2018December 23, 2024 Abstract Small and medium-sized enterprises (SMEs) contribute to China’s economic growth and help maintain social stability. However, SME business leaders have cited access to finance as an obstacle of SMEs’…
Healthcare Fund… Venture Capital in Life Sciences (III): Monoclonal Antibodies in the Treatment of Ankylosing Spondylitis 16 Apr 2014April 19, 2014 The application of monoclonal antibody drugs is a relatively new innovation. Approximately 54% of monoclonal antibody drugs available are applied in various types of cancer, although clinical trials are also…
Healthcare Fund… Venture Capital in Life Sciences (II): Pharmacogenomics and Personalized Medicine 7 Apr 2014April 7, 2014 Pharmacogenomics focuses on understanding the response rates and side effects of a treatment at the individual level. It analyzes the influence of genetic variation on drug response in patients by…
Healthcare Fund… Biomedicine: Healthcare Venture Capital’s Investment of 2014 30 Mar 2014April 1, 2014 As a venture capitalist, I believe the hottest investment of 2014 is in the healthcare sector. The beauty of healthcare investing lies in the fact that the demand for the…
Alternative Investments… Venture Capital in Life Sciences (I): Personalized Medicine for Cancer Therapies 24 Feb 2014March 17, 2014 Over the past decade, the genomics revolution has led to the emergence of numerous groundbreaking personalized medicine as well as multiple diagnostic and therapeutic targets. Take the area of cancer…
Alternative Investments… Healthcare Investing: In Innovators We Trust, Up to the Future We Light 17 Feb 2014February 22, 2014 When people talk about “healthcare,” they probably refer to pharmaceuticals and health insurers, but the sector also covers life sciences and biotechnology, medical equipment manufacturers and services, hospitals, distributors, etc.…
Private Equity… Crowdfunding: A Powerful Model of Fundraising 众筹融资 10 Feb 2014February 18, 2014 Crowdfunding is an internet-based fundraising model, where individuals network and pool their money to support a certain project or venture. A crowdfunding activity is composed of a project creator, crowd…
Alternative Investments… Impact Investing – The Next Generation of Venture Capital 20 Oct 2013October 20, 2013 In the 1990s, Jed Emerson advocated the concept of Blended Value for funds, firms, social ventures, and foundations to invest with social and environmental impact, rather than to maximize financial…
Alternative Investments… Venture Capital and Buyout 18 Oct 2013 The Yale Endowment’s investment success has been largely driven by the categories that are designed for sophisticated investors, such as PE. Ten years ending June 30, 2013, the endowment fund’s…